Kaplan-Meier plots showing influence of IDH1 mutations in the intermediate risk karyotype. Inferior EFS (A) and CRR (B) of IDH1-mutated AML (in red) compared with IDH1 wild-type cases (black) for the intermediate risk karyotype subgroup.